Shumaila et al. 2024. Long-Term Safety and Efficacy of Janus kinase (JAK) Inhibitors in the Treatment of Rheumatoid Arthritis: Disease Control in Rheumatoid Arthritis with JAK Inhibitors. DEVELOPMENTAL MEDICO-LIFE-SCIENCES. 1, 4 (Sep. 2024), 71–78. DOI:https://doi.org/10.69750/dmls.01.04.039.